lgg101

Leonard Gomella, MD

Contact Dr. Gomella

1025 Walnut Street
Suite 1112
Philadelphia, PA 19107

(215) 955-6961
(215) 923-1884 fax

Most Recent Peer-reviewed Publications

  1. Decision Support and Shared Decision Making About Active Surveillance Versus Active Treatment Among Men Diagnosed with Low-Risk Prostate Cancer: a Pilot Study
  2. Role of genetic testing for inherited prostate cancer risk: Philadelphia prostate cancer consensus conference 2017
  3. New urologic oncology drugs and the new toxicities
  4. The perlecan-interacting growth factor progranulin regulates ubiquitination, sorting, and lysosomal degradation of sortilin
  5. Intravesical rAd–IFNa/Syn3 for patients with high-grade, bacillus calmette-guerin–refractory or relapsed non–muscle-invasive bladder cancer: A phase II randomized study
  6. VAPC-1 Targeted64Cu-TP3805 kit preparation and its evaluation
  7. Prostate MRI: Value in surgical planning?
  8. Nonpalpable intratesticular mass in a young man with a history of contralateral retractile testis
  9. The urology guide to coffee and tea
  10. Prevalence and Characteristics of Patients with Suspected Inherited Renal Cell Cancer: Application of the ACMG/NSGC Genetic Referral Guidelines to Patient Cohorts
  11. Development of a voided urine assay for detecting prostate cancer non-invasively: a pilot study
  12. The Role of Therapeutic Layering in Optimizing Treatment for Patients With Castration-resistant Prostate Cancer (Prostate Cancer Radiographic Assessments for Detection of Advanced Recurrence II)
  13. The liquid biopsy for prostate cancer 25 years later
  14. Editorial Comment
  15. Prostate cancer statistics: Anything you want them to be
  16. Where have all the sperm gone?
  17. Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: The largest single-institution experience to date
  18. Hematologic Toxicity of Concurrent Administration of Radium-223 and Next-generation Antiandrogen Therapies
  19. Decipher correlation patterns post prostatectomy: Initial experience from 2 342 prospective patients
  20. v-Src oncogene induces Trop2 proteolytic activation via cyclin D1